| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Kate Rochlin is Chief Operating Officer at INAB. Kate Rochlin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $9K at current prices.
Net of sales, the INAB filings show accumulation of 5,263 shares.
Kate Rochlin has 15 Form 4 filings on record from February 2022 to May 2026, all as President and COO at IN8bio (INAB), 2022–2026.
The 24 reported transactions were 16 option or other derivative awards, 3 stock awards, 3 dispositions back to the company and 1 option exercise, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 5,263 shares of INAB at an average $1.90 on August 16, 2022, about $10K. Twelve months later INAB was down 37%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | INAB In8bio, Inc. | Chief Operating Officer | Buy | 5,263 | $1.90 | $9,999.70 | New | -19.6% | -37.0% |